Notice concerning the Establishment of OPhrs Co., Ltd.
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; “ONO”) today announced that it resolved to establish OPhrs Co., Ltd. (OPhrs) as a wholly-owned subsidiary at the meeting of its Board of Directors held today.
- Purpose for establishment:
In order to further promote our growth strategy, we have decided to establish a separate company having our own recruitment system and remuneration system to strategically and actively acquire highly specialized human resources such as digital human resources and innovation human resources.
In the future, we will be committed to actively recruit highly specialized human resources by aiming to advance and speed up recruitment methods and processes toward the achievement of the medium-term management plan.
- Outline of OPhrs Co., Ltd.:
Name OPhrs Co., Ltd. Location 8-2, Kyutaromachi 1-chome Chuo-ku, Osaka Representative Mitsuhiro Takamiya Establishment July 3, 2023 (planned) Capital JPY 10 million Staff 1 person (planned) Business Planning, investigation, research, training and consulting consignment related to each of the preceding items Relationship A wholly-owned subsidiary of ONO - Future outlook
An impact of this matter on the Company’s business results for the current fiscal year would be marginal. Should there be any events to be disclosed in the future, we will announce them in a timely manner.